These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8656509)

  • 1. Importance of surrogate markers in evaluation of antiviral therapy for HIV infection.
    Deyton L
    JAMA; 1996 Jul; 276(2):159-60. PubMed ID: 8656509
    [No Abstract]   [Full Text] [Related]  

  • 2. Surrogate markers in AIDS research. Is there truth in numbers?
    Levy JA
    JAMA; 1996 Jul; 276(2):161-2. PubMed ID: 8656510
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surrogate endpoints in clinical studies exemplified by HIV infection].
    Furrer H
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1079-88. PubMed ID: 9691341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and access to viral load measure assays: the need for validation.
    Agosto M
    Update Natl Minor AIDS Counc; 1995; ():7-8. PubMed ID: 11362791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
    MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
    HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four new concepts for combatting HIV infection...and why they won't be tried anytime soon.
    PI Perspect; 1995 Dec; (no 17):1-3, 13-4. PubMed ID: 11363102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral phenotype and genotype as markers in clinical trials.
    Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S25-34. PubMed ID: 7552510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Japanese guidelines for HIV infection].
    Ota Y
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():670-6. PubMed ID: 12722299
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing the natural history of HIV disease.
    Feinberg MB
    Lancet; 1996 Jul; 348(9022):239-46. PubMed ID: 8684203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load and response to treatment of HIV.
    De Gruttola V; Fleming T; Coombs R
    N Engl J Med; 1996 Jun; 334(25):1671-2; author reply 1672-3. PubMed ID: 8628373
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
    Schreibman T; Friedland G
    Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beware of drug holidays before HIV salvage therapy.
    Hirschel B
    N Engl J Med; 2003 Aug; 349(9):827-8. PubMed ID: 12944566
    [No Abstract]   [Full Text] [Related]  

  • 14. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
    Gottlieb GS; Hawes SE; Nickle DC; Herbeck JT; Kiviat NB; Mullins JI; Sow PS
    JAMA; 2007 Feb; 297(8):805; author reply 806-7. PubMed ID: 17327518
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New biological monitoring of HIV infection].
    Morand-Joubert L
    Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
    [No Abstract]   [Full Text] [Related]  

  • 18. Closing the circle on HIV--or not.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group.
    AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1123-33. PubMed ID: 10954887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.